The UK government will lay legislation today (13 December 2023) to allow the General Medical Council (GMC) to begin the process of regulating medical
associates to expand their roles in the NHS.
This will support plans to reduce pressure on doctors and GPs and improve access for patients, the Department of Health and Social Care (DHSC) said.
Physician associates (PAs) and anaesthesia associates (AAs) will have the same levels of regulatory oversight and accountability as doctors and other regulated
healthcare professionals once the regulations come into force, which is expected at the end of 2024.
The GMC will design and deliver detailed regulatory processes for registration, education, standards and fitness to practise for both professions.
The lessons from Covid crisis applied in the future through collaboration can create a better integration between GP practices, hospitals and community
pharmacies, Pharmacists Defence Association (PDA) has proposed.
Stating that a more integrated healthcare system could enable pharmacists to provide effective and more efficient care to patients, the PDA proposed a model where
at least two pharmacists would be working in each community pharmacy, empowered, and enabled with two-way referral pathways, having more clinical input and full
access to patient records.
"Such an environment could not only help to improve communications between health professionals and increase access to services for patients, but would support
the NHS to operate more effectively."
The Pharmacists' Defence Association (PDA) has republished a three-year-old report which underscores the vital role of community pharmacists and pharmacy t
echnicians in a 'modern NHS' amid speculations that the government is set to announce plans to enhance the role of community pharmacy teams.
PDA's 2019 report which "took three year to compile" highlighted significant empirical evidence and made recommendations to develop the roles of both community
pharmacists and pharmacy technicians, and the skill mix required to meet patients' needs.
It examined in detail the role of pharmacy technicians in community pharmacy.
The PDA still that pressure on the NHS can be managed much more effectively through the better use of pharmacists and pharmacy technicians. In the community
pharmacy setting, it is evident that if the further development of the pharmacist's role is to be facilitated and pharmacists are to become more patient facing in
the future, an extended role and greater responsibility for pharmacy technicians is not only desirable, but ultimately it is essential.